{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:10:38Z","timestamp":1778245838440,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Iran University of Medical Sciences (Tehran, Iran)","award":["93-02-30-24693"],"award-info":[{"award-number":["93-02-30-24693"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.biopha.2017.01.123","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T16:01:17Z","timestamp":1485878477000},"page":"754-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress"],"prefix":"10.1016","volume":"88","author":[{"given":"Tourandokht","family":"Baluchnejadmojarad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monireh","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamileh","family":"Ghalami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.01.123_bib0005","first-page":"S21","article-title":"Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group","volume":"54","author":"de Rijk","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2017.01.123_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2047-9158-4-4","article-title":"How to optimize the treatment of early stage Parkinson's disease","volume":"4","author":"Stocchi","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.biopha.2017.01.123_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-015-0039-8","article-title":"Development of stem cell-based therapy for Parkinson's disease","volume":"4","author":"Han","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.biopha.2017.01.123_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13311-013-0242-1","article-title":"Therapy for Parkinson's disease: what is in the pipeline?","volume":"11","author":"Stocchi","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2017.01.123_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","article-title":"Targets for neuroprotection in Parkinson's disease","volume":"1792","author":"Yacoubian","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.01.123_bib0035","first-page":"41","article-title":"Nutritional value of sesame seeds","volume":"80","author":"Martinchik","year":"2011","journal-title":"Vopr. Pitan."},{"key":"10.1016\/j.biopha.2017.01.123_bib0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0973-7847.134249","article-title":"Value addition in sesame: a perspective on bioactive components for enhancing utility and profitability","volume":"8","author":"Pathak","year":"2014","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.biopha.2017.01.123_bib0045","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/nu6051931","article-title":"Antinociceptive and anti-inflammatory activities of the sesame oil and sesamin","volume":"6","author":"Monteiro","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2017.01.123_bib0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuro.2014.10.002","article-title":"Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke","volume":"45","author":"Ahmad","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.biopha.2017.01.123_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1742-2094-8-57","article-title":"Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation","volume":"8","author":"Hsieh","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.biopha.2017.01.123_bib0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12272-014-0426-1","article-title":"Protective effect of a sesamin derivative 3-bis (3-methoxybenzyl) butane-1, 4-diol on Abeta-stressed PC12 cells","volume":"38","author":"Hou","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cbi.2009.10.003","article-title":"Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats","volume":"183","author":"Khan","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2017.01.123_bib0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroscience.2012.11.057","article-title":"Sesamin suppresses activation of microglia and p44\/42 MAPK pathway, which confers neuroprotection in rat intracerebral hemorrhage","volume":"232","author":"Ohnishi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2017.01.123_bib0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4161\/oxim.1.1.6958","article-title":"Sesamin modulates tyrosine hydroxylase superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress","volume":"1","author":"Lahaie-Collins","year":"2008","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2017.01.123_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2015.01.003","article-title":"Effects of (\u2212)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models","volume":"83-84","author":"Park","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2017.01.123_bib0085","first-page":"5","article-title":"The effect of sesamin on motor asymmetry in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease","volume":"3","author":"Baluchnejadmojarad","year":"2015","journal-title":"J. Basic Clin. Pathophysiol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0090","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.biopha.2017.01.123_bib0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejphar.2012.09.031","article-title":"The sesame lignan sesamin attenuates vascular dysfunction in streptozotocin diabetic rats: involvement of nitric oxide and oxidative stress","volume":"698","author":"Baluchnejadmojarad","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10571-015-0230-6","article-title":"Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease","volume":"36","author":"Kiasalari","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Allbutt","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2017.01.123_bib0110","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3109\/13880209.2013.803128","article-title":"Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy","volume":"51","author":"Kiasalari","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0115","first-page":"33","article-title":"Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress","volume":"14","author":"Mirshekar","year":"2010","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.biopha.2017.01.123_bib0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopha.2016.06.021","article-title":"Pelargonidin improves memory deficit in amyloid beta25-35 rat model of Alzheimer's disease by inhibition of glial activation cholinesterase, and oxidative stress","volume":"83","author":"Sohanaki","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.01.123_bib0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.freeradbiomed.2012.06.040","article-title":"S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades","volume":"53","author":"Tobon-Velasco","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2017.01.123_bib0130","first-page":"4507","article-title":"Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation","volume":"8","author":"Arya","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2017.01.123_bib0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.01.123_bib0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2017.01.123_bib0145","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3109\/13880209.2015.1008148","article-title":"Antidiabetic potential of salvianolic acid B in multiple low-dose streptozotocin-induced diabetes","volume":"53","author":"Raoufi","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pathophys.2011.03.001","article-title":"Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-diabetic rats","volume":"18","author":"Nasri","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.biopha.2017.01.123_bib0155","first-page":"33","article-title":"Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress","volume":"14","author":"Mirshekar","year":"2010","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.biopha.2017.01.123_bib0160","first-page":"227","article-title":"Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model, Iran","volume":"13","author":"Sedaghat","year":"2014","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","article-title":"Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease","volume":"36","author":"Morroni","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.biopha.2017.01.123_bib0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biopha.2016.12.109","article-title":"Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: underlying mechanisms","volume":"87","author":"Sedaghat","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.01.123_bib0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.01.123_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-014-9604-6","article-title":"The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat","volume":"30","author":"Zare","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2017.01.123_bib0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejphar.2012.10.020","article-title":"Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats","volume":"698","author":"Kalalian-Moghaddam","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2013.01.054","article-title":"Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism","volume":"1505","author":"Jalali-Nadoushan","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0205","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11064-015-1796-6","article-title":"Protective effect of oral hesperetin against unilateral striatal 6-hydroxydopamine damage in the rat","volume":"41","author":"Kiasalari","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(00)03296-0","article-title":"Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence","volume":"892","author":"Roghani","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","article-title":"Efficacy of elevated body swing test in the early model of Parkinson's disease in rat","volume":"76","author":"Roghani","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2017.01.123_bib0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2006.12.016","article-title":"Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat","volume":"205","author":"Breit","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(97)01100-1","article-title":"Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease","volume":"777","author":"Lapchak","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.physbeh.2004.04.005","article-title":"Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test","volume":"82","author":"Baluchnejadmojarad","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2017.01.123_bib0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","article-title":"Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease","volume":"230","author":"Glajch","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","article-title":"Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion","volume":"222","author":"Hsieh","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10571-015-0230-6","article-title":"Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-Hydroxydopamine rat model of Parkinson's disease","volume":"36","author":"Kiasalari","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0250","first-page":"689","article-title":"Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions","volume":"18","author":"Schwarting","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.biopha.2017.01.123_bib0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","article-title":"Genes, proteins, and neurotoxins involved in Parkinson's disease","volume":"73","author":"von Bohlen und Halbach","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0260","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mjt.0000174353.28012.a7","article-title":"Neuroprotective therapy in Parkinson disease","volume":"13","author":"Chen","year":"2006","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.biopha.2017.01.123_bib0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2014.05.045","article-title":"Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat","volume":"1574","author":"Healy-Stoffel","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.01.123_bib0270","first-page":"5733","article-title":"Sesamin ameliorates oxidative liver injury induced by carbon tetrachloride in rat","volume":"8","author":"Lv","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0275","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s12035-014-8771-0","article-title":"Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat","volume":"51","author":"Afshin-Majd","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0280","article-title":"Impact of the chronic omega-3 fatty acids supplementation in hemiparkinsonism model induced by 6-hydroxydopamine in rats","author":"Barros","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mrgentox.2014.12.007","article-title":"6-Hydroxydopamine and lipopolysaccharides induced DNA damage in astrocytes: involvement of nitric oxide and mitochondria","volume":"778","author":"Gupta","year":"2015","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.biopha.2017.01.123_bib0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1179\/135100005X38842","article-title":"Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease","volume":"10","author":"Singh","year":"2005","journal-title":"Redox Rep."},{"key":"10.1016\/j.biopha.2017.01.123_bib0295","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/sj.npp.1301381","article-title":"Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation","volume":"32","author":"Zhou","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2017.01.123_bib0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11481-007-9070-6","article-title":"Divergent roles for tumor necrosis factor-alpha in the brain","volume":"2","author":"Sriram","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0310","doi-asserted-by":"crossref","first-page":"921941","DOI":"10.1155\/2012\/921941","article-title":"Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system","volume":"2012","author":"Bournival","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2017.01.123_bib0315","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10753-015-0270-6","article-title":"Sesamin attenuates lipopolysaccharide-induced acute lung injury by inhibition of TLR4 signaling pathways","volume":"39","author":"Qiang","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2017.01.123_bib0320","first-page":"519615","article-title":"neuroprotective properties of a standardized extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertao), as evaluated by a Parkinson's disease model in rats","volume":"2014","author":"Calou","year":"2014","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.biopha.2017.01.123_bib0325","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.01.123_bib0330","article-title":"The neuroprotective effect of dimethyl fumarate in a MPTP-mouse model of Parkinson's disease: involvement of reactive oxygen species\/nuclear factor-kappaB\/nuclear transcription factor related to NF-E2","author":"Campolo","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2017.01.123_bib0335","doi-asserted-by":"crossref","DOI":"10.2174\/1874609810666170102144233","article-title":"Oxidative stress, pro-inflammatory cytokines, and antioxidants regulate expression levels of microRNAs in Parkinson's disease","author":"Prasad","year":"2017","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.biopha.2017.01.123_bib0340","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1271\/bbb.110842","article-title":"Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons","volume":"76","author":"Hwang","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.biopha.2017.01.123_bib0345","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/MCB.01510-14","article-title":"Serum- and glucocorticoid-inducible kinase 1 confers protection in cell-based and in in vivo neurotoxin models via the c-Jun N-terminal kinase signaling pathway","volume":"35","author":"Iqbal","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2017.01.123_bib0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.fct.2013.11.017","article-title":"Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway","volume":"64","author":"Ma","year":"2014","journal-title":"Food Chem. Toxicol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216315827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216315827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:18:20Z","timestamp":1778242700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216315827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":70,"alternative-id":["S0753332216315827"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.123","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}